Study of Eye Movement Testing and Therapy

This study has been completed.

Sponsored by:	Ohio State University
Information provided by:	Ohio State University
ClinicalTrials.gov Identifier:	NCT00472485

Purpose

The purpose of this study is to determine the ability of several eye movement monitors, used in clinical practice, to identify children with poor reading eye movements. A second purpose of the study is to evaluate the effectiveness of eye movement therapy.

Condition	Intervention
Saccadic Eye Movement Deficiency Oculomotor Deficiency Oculomotor Dysfunction	Procedure: eye movement therapy

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Non-Randomized, Open Label, Historical Control, Crossover Assignment

Further study details as provided by Ohio State University:

Estimated Enrollment:

Eligibility

Ages Eligible for Study:	8 Years to 13 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Children ages 8 to 13 with saccadic eye movement deficit

Exclusion Criteria:

Previous saccadic eye movement therapy

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00472485

Locations

United States, Ohio
The Ohio State University
Columbus, Ohio, United States, 43210

Sponsors and Collaborators

Ohio State University

Investigators

Principal Investigator:

Marjean Kulp, OD, MS

Ohio State University

More Information

Study ID Numbers:	00H0185
Study First Received:	May 9, 2007
Last Updated:	July 1, 2008
ClinicalTrials.gov Identifier:	NCT00472485
Health Authority:	United States: Institutional Review Board

ClinicalTrials.gov processed this record on January 14, 2009